Veracyte (FRA:12V) Accumulated Depreciation : €0.0 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Veracyte Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Veracyte's quarterly accumulated depreciation increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€-37.6 Mil) but then stayed the same from Dec. 2024 (€-37.6 Mil) to Mar. 2025 (€0.0 Mil).

Veracyte's annual accumulated depreciation increased from Dec. 2022 (€-24.5 Mil) to Dec. 2023 (€-30.1 Mil) and increased from Dec. 2023 (€-30.1 Mil) to Dec. 2024 (€-37.6 Mil).

Veracyte Accumulated Depreciation Historical Data

The historical data trend for Veracyte's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Accumulated Depreciation Chart

Veracyte Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-13.48

-19.01

-24.53

-30.13

-37.62

Veracyte Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-37.62	-

Veracyte Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Veracyte Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Veracyte's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Veracyte Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

VCYT:USA

Address

6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.veracyte.com

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Veracyte Headlines

No Headlines